NCT03793023View on ClinicalTrials.gov

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

CompletedOBSERVATIONAL

Enrollment

2,983

Participants

Timeline

Start Date

January 5, 2016

Primary Completion Date

September 23, 2019

Study Completion Date

September 23, 2019

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Teneligliptin 20mg

Trial Locations (1)

Unknown

Ajou University Hospital, Suwon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Handok Inc.

INDUSTRY